Search
for
Sort by
Research 181–210 of 431
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Mesenchymal Stem Cells from Mouse Hair Follicles Inhibit the Development of Type 1 Diabetes
- Hair repigmentation of poliosis circumscripta in androgenetic alopecia patient treated with exosomes and fractional picosecond laser
- Cancer-Related Alopecia Risk and Treatment
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome
- Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- Alopecia Areata: Current Treatments and New Directions
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review
- Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.
- Current Development of Mesenchymal Stem Cell-Derived Extracellular Vesicles
- Exosomes in Dermatology: Emerging Roles in Skin Health and Disease
- Secretome of Mesenchymal Stromal Cells as a Possible Innovative Therapeutic Tool in Facial Nerve Injury Treatment
- Advances of Microneedles for Cancer Diagnosis and Therapy
- Hydrogels: current biomedical applications and future directions
- E-Poster
- Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions, 1–30 September 2016
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- ISID1373 - Expression of programmed cell death 1 inversely correlated with the density of CD8+ T cells infiltrating hair follicles in alopecia areata
- 1373 Expression of programmed cell death 1 inversely correlated with the density of CD8+ T cells infiltrating hair follicles in alopecia areata
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023